Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Expect the unexpected: endocarditis caused by Legionella feeleii.
Journal: Laboratory medicine
Published: May 23, 2024
MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.
Journal: Open forum infectious diseases
Published: December 28, 2023
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM).
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 13, 2023
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Journal: Open forum infectious diseases
Published: March 29, 2023
American Society for Transplantation and Cellular Therapy Series: #5-Management of Clostridioides difficile Infection in Hematopoietic Cell Transplant Recipients.
Journal: Transplantation and cellular therapy
Published: February 11, 2022
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
Journal: Nature medicine
Published: September 30, 2021
Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.
Journal: Open forum infectious diseases
Published: April 15, 2021
Remdesivir Use in the Setting of Severe Renal Impairment: A Theoretical Concern or Real Risk?
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 09, 2020
Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient.
Journal: Laboratory medicine
Published: September 21, 2020
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Journal: JAMA
Published: August 22, 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
Journal: The New England journal of medicine
Published: May 28, 2020
Last Updated: 09/26/2026